Categories AlphaGraphs, Earnings, Health Care

Bristol Myers Squibb (BMY) Q4 Earnings: Key financials and quarterly highlights

Bristol Myers Squibb (NYSE: BMY) reported fourth quarter 2021 earnings results today.

Total revenues increased 8% year-over-year to $12 billion, driven by Eliquis, Immuno-Oncology and new product portfolios.

Net earnings attributable to Bristol Myers Squibb was $2.4 billion, or $1.07 per share, compared to a net loss of $10 billion, or $4.45 per share, in the same period a year ago. Adjusted net earnings was $4.1 billion, or $1.83 per share.

For the full year of 2022, worldwide revenues are expected to be approx. $47 billion. GAAP EPS is estimated to be $3.37-3.67 while adjusted EPS is estimated to be $7.65-7.95.

Prior performance

Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!

Most Popular

CVX Earnings: Chevron reports lower revenue and profit for Q3 2024

Energy exploration company Chevron Corporation (NYSE: CVX) on Friday announced third-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation dropped to

Key highlights from Exxon Mobil Corporation’s (XOM) Q3 2024 earnings results

Exxon Mobil Corporation (NYSE: XOM) reported its third quarter 2024 earnings results today. Total revenues and other income remained relatively flat at $90 billion compared to the same period a

AAPL Earnings: Apple Q4 2024 sales rise 6% YoY, beat estimates

Apple Inc. (NASDAQ: AAPL) reported an increase in revenues for the fourth quarter of 2024. The top line came in above estimates. The gadget giant generated revenues of $94.9 billion

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top